Joined October 2012
Shakthi Ramasamy retweeted
Isabella Garganese, BS, & Shakthi Kumaran Ramasamy, MD, speak with Ripal T. Gandhi, MD, about his career in IR, the evolution of interventional oncology, his research experience, & the importance of mentorship in developing the next gen of IR specialists. evtoday.com/articles/2026-se…
2
1
6
660
Shakthi Ramasamy retweeted
WITHOUT FURTHER ADO… 📣 Our SIR RFS General Council 2026-2027! Advocating for IR trainees, advancing education and research, building community, and helping shape the future of clinical interventional radiology 🙌 #SIRRFS #IRad
5
37
2,931
As treatment options for desmoid tumors continue to expand, an increasingly important question is: Which patients may benefit from percutaneous therapy, and how should it be integrated with systemic treatment ? In our new article, “Percutaneous Management of Desmoid Tumors,” published in Current Oncology Reports, we review the evolving role of image-guided percutaneous therapies, including cryoablation and transarterial approaches. We also explore their interplay with systemic therapies, including #nirogacestat and #sorafenib, emerging sequencing and combination strategies, patient selection, and multidisciplinary decision-making. Thank you to all of our co-authors for their valuable contributions: @Gina_Landinez_ @XiaoWuMD @KiyonTavakolian @AbinSajanMD Areeb Siddiqui John Moody @kiremagarciamd Junaid Raja @kavikrishVIR Read the article: link.springer.com/article/10… @BaptistHealthSF @MiamiVasc @UABRadiology @uab_ir @MountSinaiIR @UCSF_IR @ColumbiaVIR
3
6
453
Shakthi Ramasamy retweeted
We have an incredible group of renewing trainee editorial board members on the 2026-2027 RG TEAM! Congratulations, and thank you for all you do! bit.ly/3SJuzxY #RGphx @cookyscan @CasesCookyJar @CasosCooky @RadG_Editor @HebaAlbashaMD @MariaLuciaBrunV
2
7
1
35
5,738
Shakthi Ramasamy retweeted
Amanda Rigas, MD, talks with Shakthi K. Ramasamy, MD (@drShakMD), about insights on her path to interventional radiology, the importance of mentorship, her research interests, and what lies ahead for the next generation of IR trainees. evtoday.com/articles/2026-ma…
2
2
707
Shakthi Ramasamy retweeted
Original Article: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (phase 3 RASolute 302 trial) nej.md/4nWaxvM #ASCO26 | @ASCO
8
345
29
1,190
72,980
Today marks four years since we lost my brother - a physician, away on a locums assignment. It was around 9:15 AM PST on May 21, 2022 when we last spoke. I was on my way to the gym, it felt like just another Saturday. That conversation lives with me every day. What I wouldn't give for just one more. His passing changed how I see everything. I found myself paying closer attention to what other physicians were carrying, the quiet struggles. For a while, I felt hopeful. There was real momentum building around physician wellness, and it felt like something was finally shifting. But the needle is moving in the wrong direction. Burnout rates remain at historic highs. Physicians are leaving clinical medicine faster than we can replace them. The administrative burden - prior authorizations, documentation, clunky EMRs, breaking the glass on a patient there to see YOU, continues to consume the hours that should be spent on patients, or on rest, or on simply being human. Mental health stigma in medicine hasn't gone away; if anything, the fear of career consequences keeps too many physicians suffering in silence. And we lost more colleagues to suicide this year than we should ever accept as normal. I don't have all the answers. But I know this - we have to figure it out, and we are running out of time before the profession is just a shell of itself.
4
9
69
11,085
Shakthi Ramasamy retweeted
Among patients with moderate or severe PTS, the addition of endovascular therapy to standard care resulted in less severe PTS and better quality of life at 6 months than standard care alone but with a higher risk of bleeding. Full phase 3 C-TRACT trial results and Research Summary: nejm.org/doi/full/10.1056/NE…
1
10
34
10,852
Shakthi Ramasamy retweeted
Today is the day! Incredibly excited to be organizing this year’s Hackathon alongside an incredible team. @drShakMD @ruidai_ @GreggKhodorov @linziarndt @VSinghRadiology @DigitalAngio
🚀 Big news for future IR innovators! The SIR × CAIR RFS Hackathon 2026 is happening in Toronto 👀 Med students, residents & fellows -> bring your boldest ideas to life and show off your creativity. 🗓️ April 11 & 14 - #SIR26TOR 💬 Judges: Dr. Succi - Dr. Zhao - Dr. Abraham - Dr. Machan 🔗 forms.gle/fdUemjPmpjcBhcy8A
1
2
4
757
Shakthi Ramasamy retweeted
Welcome home Reid, Victor, Christina, and Jeremy! 🫶 The Artemis II astronauts have splashed down at 8:07pm ET (0007 UTC April 11), bringing their historic 10-day mission around the Moon to an end.
6,625
104,824
10,694
382,175
86,532,394
Shakthi Ramasamy retweeted
1
2
9
732
Shakthi Ramasamy retweeted
🫀Excited to share research that I supervised as senior author, now published in @NatureMedicine: the largest global analysis of ischemic heart disease burden attributable to suboptimal diet to date. As a researcher in cardiovascular epidemiology, I've always believed that what we eat is one of the most powerful levers we have for preventing heart disease. Our data now quantify just how large that lever is, and the findings are both sobering and actionable. We assessed 13 dietary risk factors across 204 countries from 1990 to 2023. In 2023 alone, suboptimal diet was responsible for an estimated 4.06 million ischemic heart disease deaths worldwide. Key takeaways: 1️⃣ The patterns of suboptimal diet vary substantially across the globe. While developing countries most often face ischemic heart disease burden related to undernutrition and limited access to protective foods (ie, whole grains, fruits, vegetables, omega-3 fatty acids), developed countries are more commonly burdened by overconsumption of harmful dietary components (ie, processed meats, sugar-sweetened beverages). 2️⃣Global efforts have historically targeted sodium, sugar, and fat reduction. Our data suggest that promoting the intake of whole grains, nuts, fruits, and legumes deserves equal, if not greater, priority. Special thanks to the @IHME_UW for enabling this work and to the remarkable #GBD collaborators worldwide. It has been a privilege to supervise and work closely with Sooji Lee, Hayeon Lee, Yejun Son, Jae Il Shin, alongside Prof. Dong Keon Yon. Paper: nature.com/articles/s41591-0… #CardiovascularHealth #Diet #Nutrition #IHD #CAD #GBD #GlobalHealth #PublicHealth #HeartDisease #FoodIsMedicine @broadinstitute | @MGBResearchNews | @MassGenBrigham | @kh_univ
22
2
53
17,917
Shakthi Ramasamy retweeted
Today, we’re announcing the winners of the MedGemma Impact Challenge, launched in collaboration with @Kaggle. 850+ participating teams showed us how AI can help bridge global healthcare gaps. Check out the winning innovations →goo.gle/47oQG1l
29
118
10
869
66,714
Shakthi Ramasamy retweeted
🧠‼️
2
20
961
59 M with severe progressive lower urinary tract symptoms. What is the diagnosis? 🧐 Answer: 🔗 pubs.rsna.org/doi/10.1148/rg… Have a companion case? Share using #CookyBites #253. We will RT the best cases! #RGphx @cookyscan1 @RadioGraphics
7
20
2,541
Shakthi Ramasamy retweeted
142,000 participants! The largest randomized trial of a multi-cancer early detection (MCED) test failed its primary endpoint genomeweb.com/cancer/grail-f… Had the enrollment been risk-based instead of age 50, it would likely have been very positive.
16
44
6
206
111,820
Shakthi Ramasamy retweeted
Happiest Valentines Day!!! ⁦@RSNA⁩ ⁦@RadioGraphics⁩ ⁦@CasesCookyJar⁩
12
34
2,171
Shakthi Ramasamy retweeted
🧠📝 Following up! The companion editorial, “Imaging Outcomes After MMAE for cSDH,” takes a deeper dive into how embolization shapes radiologic results. A sharp look at why MMAE is changing the game. Check it out 👇 #NeuroIR #Radiology pubs.rsna.org/doi/10.1148/ra…
1
1
174